4.7 Editorial Material

RSV Immunoprophylaxis: Does the Benefit Justify the Cost?

Journal

PEDIATRICS
Volume 132, Issue 5, Pages 915-918

Publisher

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2013-2449

Keywords

viral respiratory infection; RSV prophylaxis; palivizumab; asthma

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available